Real-world effectiveness of risankizumab in psoriasis: first Sardinian multicenter 2-year experience
{{output}}
Background: Psoriasis is an immune-mediated chronic skin disease associated with multiple extracutaneous comorbidities, causing a severe quality of life impairment, whose treatment with risankizumab, a humanized anti-IL-23 monocl... ...
